{"related:n0aro52eQf0J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5":[{"title":"A practical approach to pharmaceutical policy","url":"https://elibrary.worldbank.org/doi/abs/10.1596/978-0-8213-8386-5","authors":["A Seiter"],"year":2010,"numCitations":107,"pdf":"https://openknowledge.worldbank.org/bitstream/handle/10986/2468/552030PUB0Phar10Box349442B01PUBLIC1.pdf;sequence=4","citationUrl":"http://scholar.google.com/scholar?cites=18249041564974925471&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:n0aro52eQf0J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18249041564974925471&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"elibrary.worldbank.org","p":1,"exp":1596876810146},{"title":"Cost savings of switching private sector consumption from originator brand medicines to generic equivalents","url":"https://www.who.int/healthsystems/topics/financing/healthreport/35MedicineCostSavings.pdf","authors":["A Cameron","A Cameron R Laing"],"year":2010,"numCitations":59,"pdf":"https://www.who.int/healthsystems/topics/financing/healthreport/35MedicineCostSavings.pdf","citationUrl":"http://scholar.google.com/scholar?cites=2621411014479220553&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:SY9UyG0fYSQJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2621411014479220553&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"who.int"},{"title":"仿制药与原研药的比价及其管理策略研究","url":"http://www.cqvip.com/qk/90045x/201610/670155057.html","authors":["张崖冰， 胡善联， 何江江， 杜丽侠"],"year":2016,"numCitations":1,"citationUrl":"http://scholar.google.com/scholar?cites=16276729501779454212&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:BGmvej6P4uEJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16276729501779454212&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"cqvip.com"},{"title":"Pharmaceutical reform: a guide to improving performance and equity","url":"https://elibrary.worldbank.org/doi/abs/10.1596/978-0-8213-8760-3","authors":["MJ Roberts","MJ Roberts MR Reich"],"year":2011,"numCitations":43,"pdf":"https://openknowledge.worldbank.org/bitstream/handle/10986/2353/646660PUB0Phar00Box361543B00PUBLIC0.pdf?sequence=1","citationUrl":"http://scholar.google.com/scholar?cites=13172108255686506334&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:Xjcvc6u6zLYJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13172108255686506334&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"elibrary.worldbank.org"},{"title":"Generic medicines from a societal perspective: savings for health care systems","url":"http://www.euro.who.int/__data/assets/pdf_file/0003/80445/Eurohealth14_2.pdf#page=21","authors":["E Seeley","E Seeley P Kanavos"],"year":2008,"numCitations":24,"pdf":"http://www.euro.who.int/__data/assets/pdf_file/0003/80445/Eurohealth14_2.pdf#page=21","citationUrl":"http://scholar.google.com/scholar?cites=13523632455362565872&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:8FbUHhGYrbsJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13523632455362565872&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"euro.who.int"},{"title":"International best practices for negotiating 'reimbursement contracts' with price rebates from pharmaceutical companies","url":"https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2012.1268","authors":["S Morgan","S Morgan J Daw","S Morgan J Daw P Thomson"],"year":2013,"numCitations":34,"pdf":"https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2012.1268","citationUrl":"http://scholar.google.com/scholar?cites=8725840331146580022&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:NtDEuIxpGHkJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8725840331146580022&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"healthaffairs.org"}]}